Stocks Showing Rising Market Leadership: Axsome Therapeutics Earns 82 RS Rating

By Investor's Business Daily | Nov 13, 2024 at 03:00 AM EST

The Relative Strength (RS) Rating measures stock price performance from 1 to 99. High RS ratings often precede significant market gains. Axsome Therapeutics cleared a buy point but is now out of buy range. Check for new patterns or pullbacks.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.